1Shin-ichi S,Naomi Y,Fumiki Y,et al.Endothelin A receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms.J Am Soc Nephrol,2003,14:397-406.
2Cornelia H,Alexandra SK,Theresia L,et al.Influence of hepatocyte growth factor,epidermal growth factor,and mycophenolic acid on endothelin-1 synthesis in human endothelial cells.Nephrol Dial Transplant,2001,16:2310-2316.
3Quaschning T,d'Uscio LV,Lüscher TF,et al.Greater endothelial protection by the vasopeptidase inhibitor omapatrilat compared to the ACE-inhibitor captopril in salt-induced hypertension.J Am Coll Cardiol,2000,35:248.
4Forbes JM,Jandeleit-Dahm K,Allen TJ,et al.Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure.Exp Nephrol,2001,9:309-316.
5Inman SR,Burns TE,Plott WK,et al.Addition of an endothelin receptor antagonist to modified Belzer's perfusion preservation solution mitigates the adverse effect of preretrieval warm ischemic injury on posttransplant glomerular filtration rate.Transplant Proc,2001,33:2975-2976.
6Anand R,Harry D,Holt S,et al.Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure.Gut,2002,50:111-117.
7Fujii T,Takaoka M,Ohkita M,et al.Tempol protects against ischemic acute renal failure by inhibiting renal noradrenaline overflow and endothelin-1 overproduction.Biol Pharm Bull,2005,28:641-645.
10Chunlong H,Dominique H,Paul B,et al.The effect of endothelin antagonists on renal ischaemia-reperfusion injury and the development of acute renal failure in the rat.Nephrol Dial Transplant,2002,17:1578-1585.
